CN106267358B - 一种促进成骨生长的复合纳米材料 - Google Patents
一种促进成骨生长的复合纳米材料 Download PDFInfo
- Publication number
- CN106267358B CN106267358B CN201610669722.5A CN201610669722A CN106267358B CN 106267358 B CN106267358 B CN 106267358B CN 201610669722 A CN201610669722 A CN 201610669722A CN 106267358 B CN106267358 B CN 106267358B
- Authority
- CN
- China
- Prior art keywords
- titanium dioxide
- composite nano
- nano materials
- nano
- hydroxyl butyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000012010 growth Effects 0.000 title claims abstract description 24
- 239000002086 nanomaterial Substances 0.000 title claims abstract description 21
- 230000002188 osteogenic effect Effects 0.000 title claims abstract description 20
- 239000002131 composite material Substances 0.000 title claims abstract description 19
- 230000001737 promoting effect Effects 0.000 title claims abstract description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N titanium dioxide Inorganic materials O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 229920001661 Chitosan Polymers 0.000 claims abstract description 23
- -1 hydroxyl butyl Chemical group 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 19
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 7
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 108010048734 sclerotin Proteins 0.000 claims description 10
- 238000012856 packing Methods 0.000 claims description 8
- 238000013019 agitation Methods 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 4
- 238000000593 microemulsion method Methods 0.000 claims description 4
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 239000004530 micro-emulsion Substances 0.000 claims description 2
- 206010001497 Agitation Diseases 0.000 claims 2
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 claims 1
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 claims 1
- 229940112869 bone morphogenetic protein Drugs 0.000 claims 1
- 210000000988 bone and bone Anatomy 0.000 abstract description 19
- 230000007547 defect Effects 0.000 abstract description 7
- 239000002114 nanocomposite Substances 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 238000002474 experimental method Methods 0.000 abstract description 3
- 210000003625 skull Anatomy 0.000 description 5
- 208000006735 Periostitis Diseases 0.000 description 3
- 229940036811 bone meal Drugs 0.000 description 3
- 239000002374 bone meal Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 210000003460 periosteum Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 210000003455 parietal bone Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000425571 Trepanes Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000001564 haversian system Anatomy 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 229950003937 tolonium Drugs 0.000 description 1
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
- A61L27/427—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of other specific inorganic materials not covered by A61L27/422 or A61L27/425
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Composite Materials (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Materials For Medical Uses (AREA)
Abstract
本发明涉及纳米材料领域，具体是一种促进成骨生长的复合纳米材料，由纳米二氧化钛和羟丁基壳聚糖制成。本发明将纳米TiO2与壳聚糖形成新的纳米材料：温敏性羟丁基壳聚糖二氧化钛纳米微球复合体，并通过一系列细胞分子生物学和动物学实验进行研究，提供了一种生物安全性高、可注射、可填充并促进成骨细胞生长，同时具有抗炎性和抗菌性的纳米复合材料，可作为用于骨组织缺损修复的新材料。
Description
技术领域
本发明涉及医学填充纳米材料技术领域，具体地说，是一种可用于缺损骨质的填充，促进成骨生长的纳米复合材料。
背景技术
纳米二氧化钛(TiO2)作为无机纳米材料的闪光点，已经广泛应用在包括医药和食品在内的诸多领域，但是由于它能够产生大量的活性氧，可破坏细胞膜，并可以影响蛋白质和基因，存在一定的缺陷。温敏性羟丁基壳聚糖是一种可生物降解的聚阳离子多糖，具有生物降解，具有独特的跨细胞膜的能力，具有稳定的“立体”效应，能增强纳米粒子在溶液中的稳定性，避免团聚。
但是关于将纳米TiO2与温敏性羟丁基壳聚糖组合形成新的促进成骨生长的纳米符合材料目前还未见报道。
发明内容
本发明的目的在于提供一种生物安全性高、可注射、可填充并促进成骨细胞生长，同时具有抗炎性和抗菌性的纳米复合材料。
本发明的第一方面，提供一种促进成骨生长的复合纳米材料，由纳米二氧化钛和羟丁基壳聚糖制成，所述的纳米二氧化钛和羟丁基壳聚糖的重量比是(1-3):1。
优选的，所述的促进成骨生长的复合纳米材料是采用微乳液法制备的温敏性羟丁基壳聚糖二氧化钛纳米微球复合体(缩写TiO2@CTS)。
优选的，所述的温敏性羟丁基壳聚糖二氧化钛纳米微球复合体的制备方法包括以下步骤：将纳米二氧化钛，羟丁基壳聚糖，环己烷，TritonX-100，正己醇，共同加入ddH2O，37℃磁力搅拌，所得溶液体系用PBS 3000rpm离心清洗2遍，4℃保存。
本发明的第二方面，提供上述促进成骨生长的复合纳米材料的制备方法，包括以下步骤：将纳米二氧化钛，羟丁基壳聚糖，环己烷，TritonX-100，正己醇，共同加入ddH2O，37℃磁力搅拌，所得溶液体系用PBS 3000rpm离心清洗2遍，4℃保存。
优选的，所述的促进成骨生长的复合纳米材料的制备方法，包括以下步骤：用微乳液法制备，将纳米二氧化钛50mg～150mg，羟丁基壳聚糖50mg，3～5ml环己烷，1～2mlTritonX-100，1～2ml正己醇，共同加入18ml ddH2O，37℃磁力搅拌2h，所得溶液体系用PBS3000rpm离心清洗2遍，4℃保存。
在本发明的一个优选实施例中，所述的促进成骨生长的复合纳米材料的制备方法，包括以下步骤：用微乳液法制备，将纳米二氧化钛50mg，羧丁基壳聚糖50mg，4.2ml环己烷，1mlTritonX-100，1ml正己醇，共同加入18ml ddH2O，37℃磁力搅拌2h，所得溶液体系用PBS 3000rpm离心清洗2遍，4℃保存。
本发明的第三方面，提供上述促进成骨生长的复合纳米材料在制备骨质填充材料中的应用。
本发明的第四方面，提供一种促进成骨生长的骨质填充材料，所述的促进成骨生长的骨质填充材料中包含上述复合纳米材料。
优选的，所述的促进成骨生长的骨质填充材料中上述复合纳米材料和骨形态发生蛋白(BMPs)联用。
本发明优点在于：
本发明将纳米TiO2与壳聚糖形成新的纳米材料：温敏性羟丁基壳聚糖二氧化钛纳米微球复合体，并通过一系列细胞分子生物学和动物学实验进行研究，提供了一种生物安全性高、可注射、可填充并促进成骨细胞生长，同时具有抗炎性和抗菌性的纳米复合材料，可作为替代骨粉、效果更好的新材料。
附图说明
图1.透射电镜观察及Zeta电位值。
图2.MTT比色法细胞活性检测结果。
图3.血液相容性实验结果。
图4.TiO2@CTS的成骨水平的观察。
图5.在软件中选取观察范围。
图6.在Image-Pro软件中选取新生骨区域并测量。
具体实施方式
下面结合实施例对本发明提供的具体实施方式作详细说明。
实施例1
1、TiO2@CTS的制备：
用微乳液法制备TiO2@CTS，纳米二氧化钛50mg，羧丁基壳聚糖50mg，4.2ml环己烷，1mlTritonX-100，1ml正己醇，共同加入18ml ddH2O，37摄氏度磁力搅拌2h，所得溶液体系用PBS 3000rpm离心清洗2遍，4度冰箱放置留用。
2、TiO2@CTS的表征：
应用透射电子显微镜观察形态(图1a)：TiO2呈边界清晰的球形，粒径约20-30nm，颗粒分散均匀。与壳聚糖结合后形成球形的TiO2@CTS颗粒后边界模糊，电镜观察羟基壳聚糖已成功复合至二氧化钛的表面。图1b显示三组材料的Zeta电位值分别为：壳聚糖-19mv、TiO2 8.3mv，TiO2@CTS通过静电相互作用表现出轻微的负电荷约-2.9mv。上述结果充分说明羟基-壳聚糖可以结合二氧化钛复合材料，并可用于进一步的生物学研究。
3、TiO2@CTS生物安全性评价：
应用MTT比色法检测证明，经不同浓度TiO2@CTS处理的MC3T3细胞均保持良好增长(图2)。
血液相容性实验：
如图3所示：与对照组相比，TiO2@CTS组未见明显的溶血反应，进一步证实了TiO2@CTS纳米粒子的生物安全性。
4、TiO2@CTS的成骨水平的观察：
采用12只新西兰大白兔，每只体重2.5Kg，于兔顶盖骨区制作骨缺损模型，并在各缺损区域内植入不同材料。手术过程如下：兔全身麻醉后颅顶部备皮，常规外科消毒后沿颅顶中线切开皮肤，暴露骨膜，切开颅骨骨膜，于颅骨骨膜下分离，显露顶骨。以直径5mm取骨环钻在两侧顶骨以颅骨中线对称制造4处环形骨缺损区，去除外侧颅骨板，直径5mm，深约1mm。4处环形骨缺损区分别充填：Matrigle(A组空白对照组)、TiO2@CTS(B组)、TiO2@CTS+BMPs(C组)、异种异体骨粉(D组即阳性对照组)，将软组织复位逐层缝合。术后8周处死动物，颅骨取材后应用甲苯胺蓝染色对不脱钙骨组织标本观察，评价温敏性羟基几丁糖与rhBMP-2/TiO2纳米微球缓释系统的成骨水平。
结果显示：术后1周，新西兰兔颅顶伤口均达到I期愈合，未出现伤口感染或裂开现象。术后8周，处死动物并取标本。肉眼观察A组无明显骨组织生长，B组、C组和D组可见骨组织生长。
组织病理学观察比较各组不脱钙的骨组织切片：除A组未见明显骨组织生长外(图4a)，其余3组均可见新骨组织形成，有哈弗氏管样结构出现，B组可见新骨片状形成，材料区较稀疏边缘区较致密(图4b)；C组可见骨组织形成片状互相连接，结构较均匀(图4d)；D组可见骨组织由边缘区向材料区生长(图4b)；上述实验结果证实TiO2@CTS能够有效促进成骨的生长。
骨形态测量学检查：光学显微镜(Olympus P70，日本)下不同放大倍数(×4，×10，×20，×40)观察骨组织再生情况并采集图片，使用Image-ProPlus6.0(MediaCybemetics,美国)图像分析软件，选定新生骨区域，测量新生骨组织所占面积(见图5、图6)。结果表明：A组新生骨所占面积为(2.99±5.11)％，B组为(42.23±5.69)％，C组为(63.04±4.56)％，D组为(37.71±7.23)％。经统计学分析，两两组间比较，结果A组与其他各组有明显差异，C组与B、D组有明显差异，B组与D组间无明显差异。表明TiO2@CTS具有与骨粉类似的成骨作用，而TiO2@CTS+BMPs成骨作用更好。
以上已对本发明创造的较佳实施例进行了具体说明，但本发明创造并不限于所述实施例，熟悉本领域的技术人员在不违背本发明创造精神的前提下还可做出种种的等同的变型或替换，这些等同的变型或替换均包含在本申请权利要求所限定的范围内。
Claims (5)
1.一种促进成骨生长的复合纳米材料，其特征在于，由纳米二氧化钛和羟丁基壳聚糖制成，所述的纳米二氧化钛和羟丁基壳聚糖的重量比是(1-3):1；所述的复合纳米材料是采用微乳液法制备的温敏性羟丁基壳聚糖二氧化钛纳米微球复合体；所述的温敏性羟丁基壳聚糖二氧化钛纳米微球复合体的制备方法包括以下步骤：将纳米二氧化钛，羧丁基壳聚糖，环己烷，TritonX-100，正己醇，共同加入ddH2O，37℃磁力搅拌，所得溶液体系用PBS3000rpm离心清洗2遍，4℃保存。
2.一种促进成骨生长的复合纳米材料的制备方法，其特征在于，包括以下步骤：用微乳液法制备，将纳米二氧化钛50mg～150mg，羟丁基壳聚糖50mg，3～5ml环己烷，1～2mlTritonX-100，1～2ml正己醇，共同加入18ml ddH2O，37℃磁力搅拌2h，所得溶液体系用PBS3000rpm离心清洗2遍，4℃保存。
3.根据权利要求1所述的复合纳米材料在制备骨质填充材料中的应用。
4.一种促进成骨生长的骨质填充材料，其特征在于，所述的促进成骨生长的骨质填充材料中包含权利要求1所述的复合纳米材料。
5.根据权利要求4所述的促进成骨生长的骨质填充材料，其特征在于，所述的促进成骨生长的骨质填充材料中复合纳米材料和骨形态发生蛋白联用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610669722.5A CN106267358B (zh) | 2016-08-15 | 2016-08-15 | 一种促进成骨生长的复合纳米材料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610669722.5A CN106267358B (zh) | 2016-08-15 | 2016-08-15 | 一种促进成骨生长的复合纳米材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106267358A CN106267358A (zh) | 2017-01-04 |
| CN106267358B true CN106267358B (zh) | 2019-04-12 |
Family
ID=57671053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610669722.5A Expired - Fee Related CN106267358B (zh) | 2016-08-15 | 2016-08-15 | 一种促进成骨生长的复合纳米材料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106267358B (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102850576A (zh) * | 2012-09-07 | 2013-01-02 | 中国科学技术大学 | 以壳聚糖支架组装的纳米复合支架及其制备方法和应用 |
| CN103172762A (zh) * | 2011-12-20 | 2013-06-26 | 上海其胜生物制剂有限公司 | 一种预防脑脊液漏的医用级温敏性壳聚糖封闭剂的制备方法 |
| CN103726319A (zh) * | 2013-12-09 | 2014-04-16 | 科凯精细化工（上海）有限公司 | 一种壳聚糖负载纳米二氧化钛复合物及其制备方法 |
| CN104762085A (zh) * | 2014-07-02 | 2015-07-08 | 济南大学 | 一种磁性荧光复合纳米生物探针及其制备方法 |
-
2016
- 2016-08-15 CN CN201610669722.5A patent/CN106267358B/zh not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103172762A (zh) * | 2011-12-20 | 2013-06-26 | 上海其胜生物制剂有限公司 | 一种预防脑脊液漏的医用级温敏性壳聚糖封闭剂的制备方法 |
| CN102850576A (zh) * | 2012-09-07 | 2013-01-02 | 中国科学技术大学 | 以壳聚糖支架组装的纳米复合支架及其制备方法和应用 |
| CN103726319A (zh) * | 2013-12-09 | 2014-04-16 | 科凯精细化工（上海）有限公司 | 一种壳聚糖负载纳米二氧化钛复合物及其制备方法 |
| CN104762085A (zh) * | 2014-07-02 | 2015-07-08 | 济南大学 | 一种磁性荧光复合纳米生物探针及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 乳液法制备不同形态壳聚糖微球的研究;刘国根;《中国优秀硕士学位论文全文数据库 工程科技I辑》;20071115(第5期);第41、43页 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106267358A (zh) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Electroactive barium titanate coated titanium scaffold improves osteogenesis and osseointegration with low-intensity pulsed ultrasound for large segmental bone defects | |
| Zhang et al. | Multilayered titanium carbide MXene film for guided bone regeneration | |
| Li et al. | Evaluation of 3D-printed polycaprolactone scaffolds coated with freeze-dried platelet-rich plasma for bone regeneration | |
| Lanao et al. | Bone response to fast-degrading, injectable calcium phosphate cements containing PLGA microparticles | |
| Park et al. | Tissue engineering bone-ligament complexes using fiber-guiding scaffolds | |
| Sun et al. | Alveolar ridge preservation using an open membrane approach for sockets with bone deficiency: A randomized controlled clinical trial | |
| Salamanna et al. | Nano-based biomaterials as drug delivery systems against osteoporosis: a systematic review of preclinical and clinical evidence | |
| Toledano et al. | Doxycycline and zinc loaded silica-nanofibrous polymers as biomaterials for bone regeneration | |
| TW201240682A (en) | Non-woven fabric containing bone prosthetic material | |
| Spałek et al. | Biocompatible materials in otorhinolaryngology and their antibacterial properties | |
| Murgia et al. | Development of a multifunctional bioerodible nanocomposite containing metronidazole and curcumin to apply on L-PRF clot to promote tissue regeneration in dentistry | |
| Ahmadi et al. | Efficient osteoblastic differentiation of human adipose-derived stem cells on TiO2 nanoparticles and metformin co-embedded electrospun composite nanofibers | |
| Xu et al. | Immunology and bioinformatics analysis of injectable organic/inorganic microfluidic microspheres for promoting bone repair | |
| Paci et al. | Piezoelectric nanocomposite bioink and ultrasound stimulation modulate early skeletal myogenesis | |
| Bi et al. | Collagen-coated poly (lactide-co-glycolide)/hydroxyapatite scaffold incorporated with DGEA peptide for synergistic repair of skull defect | |
| Bassi et al. | Bone regeneration assessment of polycaprolactone membrane on critical-size defects in rat calvaria | |
| Chen et al. | In vitro and in vivo studies of hydrophilic electrospun PLA95/β-TCP membranes for guided tissue regeneration (GTR) applications | |
| Ho et al. | A novel HA/β-TCP-collagen composite enhanced new bone formation for dental extraction socket preservation in beagle dogs | |
| Fouad et al. | Porous polyethylene coated with functionalized hydroxyapatite particles as a bone reconstruction material | |
| Eldeeb et al. | Dual-drug delivery via zein in situ forming implants augmented with titanium-doped bioactive glass for bone regeneration: Preparation, in vitro characterization, and in vivo evaluation | |
| Sadeghzadeh et al. | A review on the effect of nanocomposite scaffolds reinforced with magnetic nanoparticles in osteogenesis and healing of bone injuries | |
| Li et al. | Alginate/Gelatin hydrogel scaffold containing nCeO2 as a potential osteogenic nanomaterial for bone tissue engineering | |
| CN109395175A (zh) | 引导组织再生膜及其制备方法 | |
| Wang et al. | Enhancement of bone-forming ability on beta-tricalcium phosphate by modulating cellular senescence mechanisms using senolytics | |
| Boda et al. | β-Tricalcium phosphate-modified aerogel containing PVA/chitosan hybrid nanospun scaffolds for bone regeneration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190412 |